US FDA Integrity Erosion: Unpacking the Intersection of Politics and Regulatory Capture
Original framing: “[Editorial] Politicisation of the US FDA: eroding integrity and trust” — The Lancet
The FDA's scientific standards and rigorous review processes are critical to ensuring the safety and efficacy of medicines. However, the agency's ability to maintain these standards is compromised by the increasing politicization of its decision-making processes.
The politicization of the FDA threatens to undermine the agency's integrity and trust, with significant implications for public health outcomes and the future of healthcare in the US and globally.
To address this trend, it is essential to strengthen the agency's independence, promote global regulatory cooperation, and engage marginalized communities in the regulatory decision-making process. By taking a systemic approach to regulatory governance, we can ensure that the FDA's decisions are guided by scientific evidence, rigorous review, and a commitment to fairness, equity, and effectiveness.